|
|
Incorporated in 1973, Alkem Labs is leading India based pharmaceutical company engaged in the development, manufacture and sale of pharmaceutical and neutraceutical products.
Alkem Labs produces branded generics, generic drugs, active pharmaceutical ingredients and neutraceuticals, which they market in India and 55 countries internationally, primarily the United States.
Company's pharmaceutical business is organized into domestic and international operations. Alkem Labs has a portfolio of over 736 brands in India. Company's most significant therapeutic areas in domestic market are anti-infectives, gastro-intestinal, pain and analgesics, and vitamins, minerals and nutrients.
Alkem Labs have a total of 16 manufacturing facilities: 14 manufacturing facilities at five locations in India and two in the United States. Company have four research and development facilities, two in India and two in the United States. As of June 30, 2015, company employed 483 scientists in research and development functions.
Highlights:
1. Alkem Labs is 5th largest pharmaceutical company in India in terms of domestic sales.
2. Alkem Labs products are also sold in 56 countries. In the United States, company has filed 66 abbreviated new drug applications.
3. Company sells a range of high-quality, cost effective generic drugs to major drug chains, pharmaceutical retailers, wholesalers, food and grocery stores, distributors and managed care companies in the United States.
| Particulars | For the year/period ended (in Rs. Million) | |||
| 31 Mar 15 | 31 Mar 14 | 31 Mar 13 | 31 Mar 12 | |
| Total Income | 33,595.20 | 28,395.80 | 24,690.10 | 20,640.10 |
| Profit After Tax (PAT) | 4,370.90 | 4,402.00 | 4,667.80 | 4,318.10 |
The objects of the Offer are:
1. To achieve the benefits of listing the Equity Shares on the Stock Exchanges and
2. For the sale of 12,853,442 Equity Shares by the Selling Shareholders.
| Alkem Laboratories IPO Date | Dec 8, 2015 to Dec 10, 2015 |
| Alkem Laboratories IPO Face Value | ₹2 per share |
| Alkem Laboratories IPO Price | ₹1020 to ₹1050 per share |
| Alkem Laboratories IPO Lot Size | 14 Shares |
| Issue Size | 12,853,442 shares of ₹2 (aggregating up to ₹1,349.61 Cr) |
| Issue Type | Book Built Issue IPO |
| Listing At | BSE, NSE |
| Company Promoters | Alkem Labs has 23 Promoters who jointly hold 64,302,440 Equity Shares of the Company which, in aggregate, constitutes 53.8% of the issued and paid-up Equity Share capital of our Company. |
The Alkem Laboratories IPO lot size is 14 shares. A retail-individual investor can apply for up to 13 lots (182 shares or ₹191,100).
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Minimum | 1 | 14 | ₹14,700 |
| Maximum | 13 | 182 | ₹191,100 |
Considering company's position, popular brands in the pharma sector and the given track records with over 22% CAGR in revenue growth for last five fiscals and over 36% growth in first half of current fiscal, reasonable pricing, it's a worthy bet for short to long term.
Read detail review...
Alkem Laboratories IPO Recommendation by Members Alkem Laboratories IPO Recommendations Details | Post Recommendation | Manage Recommendations
| Subscribe | Neutral | Avoid |
|---|---|---|
| 0 | 0 | 0 |
No Record Found.
The Alkem Laboratories IPO is subscribed 44.29 times on Dec 10, 2015 11:15:00 PM. The public issue subscribed 3.17 times in the retail category, 57.19 times in the QIB category, and 129.96 times in the NII category. Check Day by Day Subscription Details (Live Status)
| Category | Subscription (times) |
|---|---|
| QIB | 57.19 |
| NII | 129.96 |
| Retail | 3.17 |
| Employee | 0.67 |
| Total | 44.29 |
| Listing Date | Wednesday, December 23, 2015 |
| BSE Script Code | 539523 |
| NSE Symbol | ALKEM |
| Listing In | B Group of Securities |
| ISIN | INE540L01014 |
| IPO Price | ₹1050 per share |
| Face Value | ₹2 per share |
|
|
|
Alkem Laboratories Limited
Alkem House,
Senapati Bapat Marg,
Lower Parel, Mumbai 400 013
Phone: +91 22 3982 9999
Email: investors@alkem.com
Website: http://www.alkemlabs.com/
Link Intime India Private Ltd
Phone: +91-22-4918 6270
Email: all.ipo@linkintime.co.in
Website: https://linkintime.co.in/
Alkem Laboratories IPO is a main-board IPO of 12,853,442 equity shares of the face value of ₹2 aggregating up to ₹1,349.61 Crores. The issue is priced at ₹1020 to ₹1050 per share. The minimum order quantity is 14 Shares.
The IPO opens on Dec 8, 2015, and closes on Dec 10, 2015.
Link Intime India Private Ltd is the registrar for the IPO. The shares are proposed to be listed on BSE, NSE.
The Alkem Laboratories IPO opens on Dec 8, 2015 and closes on Dec 10, 2015.
Alkem Laboratories IPO lot size is 14 Shares and the minimum order quantity is .
You can apply in Alkem Laboratories IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services. Read more detail about apply IPO online through Zerodha, Upstox, 5Paisa, Edelweiss, ICICI Bank, HDFC Bank and SBI Bank.
The finalization of Basis of Allotment for Alkem Laboratories IPO will be done on [.], and the allotted shares will be credited to your demat account by [.]. Check the Alkem Laboratories IPO allotment status.
Useful Articles
|
|
IPO Guru (4000+ Posts, 4600+ Likes)
